Abstract
We describe a case of acute myocardial ischemia following carmustine treatment during the BEAM regimen. Despite this, full completion of the autologous peripheral stem-cell transplant was possible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Salloun E, Jillella AP, Nadkarni R et al. Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation Cancer 1998 82: 1506 1512
Kanj SS, Sharara AI, Shpall EJ et al. Myocardial ischemia associated with high-dose carmustine infusion Cancer 1991 68: 1910 1912
Takvorian T, Parker LM, Hochberg FH et al. Autologous bone marrow transplantation: host effects of high-dose BCNU J Clin Oncol 1983 1: 610 620
Phillips GL, Fay JW, Herzig GP et al. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC#4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I–II study Cancer 1983 55: 1792 1802
Henner W, Peters WP, Eder JP et al. Pharmacokinetics and immediate effects of high-dose carmustine in man Cancer Treat Rep 1986 70: 877 880
Van Besien K, Tabacoff J, Rodriguez M et al. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity Bone Marrow Transplant 1995 15: 549 555
Peters WP, Roderheaver DP, Mendel DB et al. Effects of high dose alkylating agents on endomyocardial glutathione levels and cardiac performance Proc Am Assoc Cancer Res 1988 29: 268 273
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Genet, P., Pulik, M., Gallet, B. et al. Acute myocardial ischemia after high-dose therapy with BEAM regimen. Bone Marrow Transplant 30, 253–254 (2002). https://doi.org/10.1038/sj.bmt.1703632
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703632
Keywords
This article is cited by
-
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
Bone Marrow Transplantation (2021)
-
Carmustine infusion reactions are more common with rapid administration
Supportive Care in Cancer (2012)